{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T06:26:19Z","timestamp":1781677579914,"version":"3.54.5"},"reference-count":15,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2001,12,21]],"date-time":"2001-12-21T00:00:00Z","timestamp":1008892800000},"content-version":"vor","delay-in-days":234,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J of Urology"],"published-print":{"date-parts":[[2001,5]]},"abstract":"<jats:p><jats:bold>Abstract<\/jats:bold><jats:bold> Background:<\/jats:bold> A recurrence of bladder tumors following surgery for transitional cell carcinoma of the upper urinary tract is not rarely observed. A prospective randomized study was conducted to examine the significance of prophylactic intravesical instillation of mitomycin C (MMC) and cytosine arabinoside (Ara\u2010C) to prevent recurrent bladder tumors after surgery for superficial transitional cell carcinoma of the upper urinary tract.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> The patients were randomized into an instillation group, who received postoperative intravesical instillation of MMC (20 mg) and Ara\u2010C (200 mg) 28 times over a period of 2 years, and a non\u2010instillation group. The non\u2010recurrence rate was then compared between the groups.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Of the 27 patients registered, 25 patients (13 with instillation and 12 without instillation) were able to be evaluated, with a median follow\u2010up period of 45 months. The non\u2010recurrence rate of bladder tumors in the instillation group was higher than that in the non\u2010instillation group. Although the difference was not statistically significant, the <jats:italic>P<\/jats:italic>\u2010value (<jats:italic>P<\/jats:italic> = 0.079) demonstrated a strong trend. When any possible bias was allowed for a multivariate analysis, the difference was almost significant (<jats:italic>P<\/jats:italic> = 0.0567). No patients withdrew from this study due to any side\u2010effects.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> The postoperative instillation of MMC and Ara\u2010C may be a useful approach for reducing the recurrence of bladder tumors after surgery for upper urinary tract tumors.<\/jats:p>","DOI":"10.1046\/j.1442-2042.2001.00286.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T02:04:26Z","timestamp":1047434666000},"page":"212-216","source":"Crossref","is-referenced-by-count":40,"title":["Prophylactic intravesical instillation of mitomycin C and cytosine arabinoside for prevention of recurrent bladder tumors following surgery for upper urinary tract tumors: A prospective randomized study"],"prefix":"10.1111","volume":"8","author":[{"given":"Naotaka","family":"Sakamoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Naito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joichi","family":"Kumazawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asami","family":"Ariyoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukio","family":"Osada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuo","family":"Omoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhito","family":"Fujisawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichikirou","family":"Morita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"The Kyushu University Urological Oncology Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2001,12,21]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1159\/000471683"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.1991.tb15064.x"},{"key":"e_1_2_5_4_2","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/BF00256725","article-title":"Japanese Urological Cancer Research for Adriamycin. Randomized clinical trial on chemoprophylaxis of recurrence in cases of superficial bladder cancer.","volume":"11","author":"Niijima T","year":"1983","journal-title":"Cancer Chemother. Pharmacol."},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0090-4295(82)90125-X"},{"key":"e_1_2_5_6_2","first-page":"852","article-title":"Prophylactic intravesical chemotherapy for bladder tumor after surgery of upper tract urothelial carcinoma.","volume":"33","author":"Tari K","year":"1987","journal-title":"Acta Urol. Jpn."},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.5980\/jpnjurol1989.81.1857"},{"key":"e_1_2_5_8_2","first-page":"183","volume-title":"TNM Classification of Malignant Tumors","author":"International Union Against Cancer","year":"1997"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19881101)62:9<2016::AID-CNCR2820620924>3.0.CO;2-G"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.2307\/2529747"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/0090-4295(76)90557-4"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)55976-5"},{"key":"e_1_2_5_13_2","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1159\/000473519","article-title":"Prophylactic chemotherapy of superficial transitional cell bladder carcinoma: An EORTC randomized trial comparing thiotepa, an epipodophyllotoxin (VM 26) and TUR alone.","volume":"8","author":"Schulman CC","year":"1982","journal-title":"Eur. Urol."},{"key":"e_1_2_5_14_2","first-page":"428","article-title":"p53 mutations in multiple urothelial carcinomas: A molecular analysis of the development of multiple carcinomas.","volume":"10","author":"Goto K","year":"1997","journal-title":"Mod. Pathol."},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1078-1439(99)00015-0"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1097-0142(19991101)86:9<1818::aid-cncr25>3.3.co;2-s"}],"container-title":["International Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1442-2042.2001.00286.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1442-2042.2001.00286.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T10:03:19Z","timestamp":1697623399000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1442-2042.2001.00286.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,5]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2001,5]]}},"alternative-id":["10.1046\/j.1442-2042.2001.00286.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1442-2042.2001.00286.x","archive":["Portico"],"relation":{},"ISSN":["0919-8172","1442-2042"],"issn-type":[{"value":"0919-8172","type":"print"},{"value":"1442-2042","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,5]]}}}